Isocyanates
Aobchem 3-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 207681-67-2 | C9H10BrNO2 | 10g
3-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 207681-67-2 | C9H10BrNO2 | 10g
Aobchem 2-Chloro-6-fluoro-3-methylbenzyl alcohol | ≥95% | CAS 261762-83-8 | C8H8ClFO | 5g
2-Chloro-6-fluoro-3-methylbenzyl alcohol | ≥95% | CAS 261762-83-8 | C8H8ClFO | 5g
Aobchem 2-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 899425-05-9 | C9H10BrNO2 | 1g
2-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 899425-05-9 | C9H10BrNO2 | 1g
Aobchem 2-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 899425-05-9 | C9H10BrNO2 | 500mg
2-Bromo-N-methoxy-N-methylbenzamide | ≥97% | CAS 899425-05-9 | C9H10BrNO2 | 500mg
Aobchem 2-Chloro-6-fluoro-3-methylbenzonitrile | ≥95% | CAS 886500-98-7 | C8H5ClFN | 5g
2-Chloro-6-fluoro-3-methylbenzonitrile | ≥95% | CAS 886500-98-7 | C8H5ClFN | 5g
Aobchem 4-Bromo-5-hydroxy-2-methylbenzoic acid | ≥95% | CAS 1781204-48-5 | C8H7BrO3 | 1g
4-Bromo-5-hydroxy-2-methylbenzoic acid | ≥95% | CAS 1781204-48-5 | C8H7BrO3 | 1g
Cayman Chemical 14 15EpETE Fatty Acids and Der
EDHF is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (NO) and COX-derived (prostacyclin) vasodilators.{6485,7204} CYP450 metabolism of PUFAs, produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator.{5826} However, the CYP450 metabolites of EPA (Item No. 90110) and DHA (Item No. 90310) have been little studied relative to arachidonate epoxygenase metabolites. (±)14(15)-EpETE is the ω-3 homolog of (±)14(15)-EpETrE, derived via epoxidation of the 14,15-double bond of EPA. The EDHF activity of (±)14(15)-EpETE has not yet been determined.
Cayman Chemical 14 15EETSI Fatty Acids and Der
A metabolically stable methyl sulfonamide analog of 14(15)-EET; equipotent to 14(15)-EET in vascular agonist activity
Cayman Chemical 16 17EpDPA Fatty Acids and Der
A DHA metabolite derived via epoxidation of the 16,17-double bond; epoxygenase metabolites of DHA have been detected in a mouse model of inflammation
Cayman Chemical 14 15EpEDE Fatty Acids and Der
An EpEDE acid formed from DGLA, either by a strong oxidizing agent or by cytochrome P450 epoxygenases; biological properties are poorly understood
Cayman Chemical 19 20EpDPA Fatty Acids and Der
An epoxide metabolite of DHA; formed from DHA by various CYP isoforms; suppresses hCLS formation and liver fibrosis in wild-type mice in a model of NASH at 100 ng/animal, i.p., intraplantar administration induces acute mechanical hyperalgesia in mice
Aobchem 5-Bromo-2-hydroxy-3-methylbenzyl alcohol | ≥95% | CAS 77691-33-9 | C8H9BrO2 | 250mg
5-Bromo-2-hydroxy-3-methylbenzyl alcohol | ≥95% | CAS 77691-33-9 | C8H9BrO2 | 250mg
eMolecules 622-58-2 | P-Tolyl isocyanate | Combi-Blocks | MFCD00002029 | 133.150 | C8H7NO | 98.000 | Cc1ccc(cc1)N=C=O | 5g | 388715426
P-Tolyl isocyanate | Combi-Blocks | 622-58-2 | MFCD00002029 | 133.150 | C8H7NO | 98.000 | Cc1ccc(cc1)N=C=O | 5g | 388715426